Investors

British Business Investments is an institutional investor backing funds including Arāya Ventures.

British Patient Capital operates a £375m programme called Future Fund: Breakthrough, co-investing with private sector investors in R&D-intensive UK companies.

CARB-X is a global non-profit partnership dedicated to accelerating antibacterial research to tackle the rising threat of drug-resistant bacteria.

CDP Venture Capital manages multiple funds with substantial assets and is owned by CDP Equity and Invitalia.